Navigation Links
Unique Simulation Training Course Ushers in New Era of Stroke Intervention
Date:6/3/2008

SCAI Trains Interventional Cardiologists to Stop Strokes

WASHINGTON, June 3 /PRNewswire/ -- In the event of a stroke, every second counts in saving brain tissue and preventing disability or even death. Through hands-on simulation, physicians are learning to capture and remove blood clots in the brain through catheter-based treatments similar to the life-saving treatments used to stop a heart attack. To train interventional cardiologists and vascular specialists in what is called neuro-rescue, or stroke intervention, the Society for Cardiovascular Angiography and Interventions (SCAI) launched the first interactive, simulation-based stroke intervention course, "SCAI Core Curriculum in Introductory Neuro Rescue."

The program, developed for cardiologists already experienced in coronary and carotid artery stenting, introduces physicians to acute stroke intervention and provides hands-on simulation in clot removal. Each session is limited to 20 experienced interventional cardiologists in order to provide extensive hands-on training, allowing participants to practice removing clots from the brain on a unique simulation system. Clots are removed using a newly FDA-approved catheter-based clot-retrieval device. Physicians thread a guidewire to the clot through the carotid arteries in the neck. The wire is threaded through the clot, and when the device is deployed, the coiled wire wraps around the clot, acting like a basket and allowing the physician to pull the whole clot from the body and restore blood flow to the brain.

"In the event of a heart attack, 'time is muscle,' and in the event of a stroke, 'time is brain tissue.' Quick intervention can mean the difference between a full recovery and disability or even death," said Christopher U. Cates, MD, FSCAI, Director of Vascular Intervention at Emory Hospitals in Atlanta, and SCAI Secretary and Program/Course Director. "Cardiologists who participated in the course were able to practice removing a clot from the brain in the cardiac cath lab under the simulated circumstances that match what they would experience while treating a stroke patient. They practiced using the new interventional devices and experienced what it looks like and even what it feels like to remove the clot from the blood vessels of the brain."

An estimated 750,000 people experience a stroke each year in the United States. Stroke is the No. 3 killer of Americans, responsible for one of every 16 deaths, and the top cause of adult disability in the United States. In 2007, representatives from interested medical disciplines, industry and government convened the first Stroke Roundtable to develop guidelines and conduct research on stroke. SCAI was the first organization to launch a stroke intervention course in late 2007, "Advanced Course in Carotid Stenting," and the Introductory Neuro Rescue course is the first course of its kind to provide acute stroke intervention simulation training for cardiologists.

"Interventional treatments are the future of stroke care. With advances in treating carotid artery disease with stenting, it is important for cardiologists to be trained to stop strokes," said Bonnie H. Weiner, MD, MSEC, MBA, FSCAI, SCAI Immediate Past President. "New interventional treatments are showing great promise in stopping stroke, just as similar treatments have revolutionized heart attack care over the past 30 years and dramatically reduced death rates."

A key challenge now is to train a sufficient number of physicians around the country to deliver these important treatments and raise awareness among patients about the importance of seeking care quickly if they experience symptoms of stroke, Dr. Weiner said. As the procedure evolves, SCAI will also work with other societies and agencies to assess the effectiveness of these interventions against existing benchmarks for the treatment of stroke.

"Stroke remains a leading cause of disability and death worldwide. We hope that interventional treatments will have the same impact on stroke outcomes that they have had on heart attack outcomes over the past three decades," said Ziyad M. Hijazi, MD, MPH, FSCAI, President of SCAI. "Interventionalists are able to transfer their experience in catheter-based treatments from the heart to the brain, and together with neurologists and other specialists, we have the opportunity to dramatically impact the effects of stroke."

Health professionals and patients can find more information about stroke and advances in interventional stroke treatments at http://www.Seconds-Count.org/stroke.

About SCAI

Headquartered in Washington, D.C., the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in more than 60 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's annual meeting has become the leading venue for education, discussion, and debate about the latest developments in this dynamic medical specialty. SCAI's new patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit http://www.scai.org or http://www.seconds-count.org.

Contacts Available for Interview:

Christopher U. Cates, M.D., FSCAI

Secretary, Society for Cardiovascular Angiography and Interventions

Director of Vascular Intervention

Emory Hospitals, Atlanta, Georgia

Tel: 717-422-1181

Email: pr@scai.org

Ziyad M. Hijazi, M.D., MPH, FSCAI

President, Society for Cardiovascular Angiography and Interventions

Professor of Pediatrics and Internal MedicineRush Center for Congenital

and Structural Heart Disease, Chicago

Tel: 717-422-1181

Email: pr@scai.org

Bonnie H. Weiner, M.D., MSEC, MBA, FSCAI

Immediate Past President, Society for Cardiovascular Angiography

and Interventions

Professor of Medicine and Director of Interventional Cardiology Research

St. Vincent Hospital at Worcester Medical Center

Worcester, Massachusetts

Tel: 717-422-1181

Email: pr@scai.org


'/>"/>
SOURCE Society for Cardiovascular Angiography and Interventions
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 2701 Australian: A Unique Partnership
2. Moonview Sanctuary Releases First Case Study of Client Treated Using Unique Moonview Model
3. Arctic explorer delivers unique snow-depth data for CryoSat
4. Study finds unique HIV vaccine formula elicits strong immune responses
5. Anthem Blue Cross and Blue Shield in New Hampshire Announces Unique Enhancement to its ePrescribing Program
6. Upscale Seattle-Based Skincare Clinic Expands Into California With Unique Custom Tailored Skincare Approach
7. Champion Health: Learn How to Create a Unique, Personalized Health Plan That Works and Keeps Working
8. Womans Abdominal Organs Removed in Unique Cancer Surgery
9. LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo
10. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
11. Unique Line of Custom-Made Orthotics for Sandals and Clogs Cater to Style-Minded Foot Pain Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... Horizon Goodwill Industries, SourceAmerica and ... high school girls succeed in STEM programs as well as help Horizon Goodwill ... over 20 high school girls at their corporate headquarters on Tuesday, July 25, ...
(Date:7/24/2017)... ... 2017 , ... The International Essential Tremor Foundation (IETF) will host a free ... The seminar will take place on Saturday, Aug. 26 at the Embassy Suites by ... run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The ...
(Date:7/24/2017)... NY (PRWEB) , ... July 24, 2017 , ... ... series of media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn ... elements is one of the leading causes of long term skin conditions, including ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the ... announces the issuance of United States Patent Number 9,695,398 (the '398 patent) and ... The '398 and '324 patents cover methods and systems for optimizing fat ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the nationally ... on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about an ... China. , The article by Zidor Aldama described the situation in which Chinese children ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
(Date:6/30/2017)... , June 30, 2017 In vitro ... the start of May, at least ten diagnostic companies ... private investments, public offerings and a loan facility.  The ... to almost $80 million.  Kalorama Information provides a monthly ... its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: